@TevogenBio Profile picture

Tevogen Bio

@TevogenBio

Specialty immunotherapy biotech developing off-the-shelf precision #Tcell therapeutics in #oncology, #neurology, and #virology. $TVGN

Joined March 2021
Similar User
+ BERLIN BUYERS CLUB + photo

@BerlinBuyers

Post-Viral Trials News photo

@postviraltrials

GeNeuro photo

@GeneuroO

Amie Bishop photo

@amiejobishop

BioAnalysis LLC photo

@BioAnalysisLLC

Ryan Saadi, CEO, Tevogen Bio ($TVGN @nasdaq) photo

@CEO_TEVOGEN_BIO

Derek Moss photo

@Derek_R_Moss

Patrick231aa photo

@Patrick33264855

This is M.E. tweeting photo

@ThisisMEtweety

Windy Tanner photo

@windytanner

Schinkou photo

@schinkou

Link: tinyurl.com/3at5cwu8 “I commend Tevogen’s leadership for steering the company’s remarkable growth strategy. With over three decades in this sector, I see Tevogen’s significant achievements since inception as a testament to the strength of our efficient business model.…

Tweet Image 1

Vision Drives, Experience Delivers. $TVGN

Vision Drives, Experience Delivers : Respected industry-wide, Tevogen Leadership brings a combined 300+ years track record of success in drug development, commercialization, investment banking, and leadership in the emerging field of artificial intelligence in biopharma. $tvgn…

Tweet Image 1


Link: tinyurl.com/45t3wnwr · Improved operating performance by reducing net loss by $52.5 million; reported net loss of $4.3 million and $56.8 million for the nine months ended September 30, for 2024 and 2023, respectively. · Significantly improved financial position by…

Tweet Image 1

Tevogen Bio Reposted

In just four short years, a bold vision has grown into @TevogenBio - a thriving #biotech built with less than $40 million in total investment. The success story could not be written without its people, I call Team Tevogen, who believed it was impossible to fail and deployed every…

Tweet Image 1

Link: tinyurl.com/5n7ysxm2 · Our financing options must consider preserving shareholder value and the potential equity dilution of warrant conversion at a strike price of $11.50 per share which could provide the company with over $200 million. · Since its founding in 2020,…

Tweet Image 1

"Tevogen Bio is aware of disinformation being used by individuals with the intent to harm our company's reputation and stock price. We will continue to monitor and are working with the appropriate authorities to investigate these false claims." - William Keane, Vice President of…

Tweet Image 1

Link: tinyurl.com/2p92wktn · Since its founding in 2020, Tevogen Bio has developed a significant asset portfolio, and kept expenditures under $40 million, a fraction of the industry norm. · Tevogen’s success would not be possible without its passionate team united by a…

Tweet Image 1

"Transient quick wins or impressive numbers may give the illusion of success, but true success is sustainable and cannot be achieved without bringing everyone on the journey — be it a company or an entire society. Aim to create a lasting impact that leaves no one behind; success…

Tweet Image 1

As we prepare to file our most recent quarterly financials, I want to highlight that Tevogen Bio has the funding it needs to sustain its operations and continue executing our strategy. We remain attentive to enhancing shareholder value, which is always top of mind for our team as…

Tweet Image 1

Tevogen Bio is aware of disinformation being used by individuals with the intent to harm our company’s reputation and stock price. We will continue to monitor and are working with the appropriate authorities to investigate these false claims" communicates the response…

Tweet Image 1

We mourn, we honor, and we uphold the values our heroes cherished more than life itself. The ideals of America live on because of the men and women who defend them. $TVGN #VeteransDay

Tweet Image 1

Link: tinyurl.com/jhuczmxa Kirti Desai, Tevogen Bio’s Chief Financial Officer, commented, “As we prepare to file our most recent quarterly financials, I want to highlight that Tevogen Bio has the funding it needs to sustain its operations and continue executing our strategy.…

Tweet Image 1

Loading...

Something went wrong.


Something went wrong.